Esprit BTK Everolimus Eluting Resorbable Scaffold System
Esprit BTK is a Bioresorbable Drug Eluting Stent system indicated for improving luminal diameter in infrapopliteal lesions in patients with chronic limb-threatening ischemia (CLTI).
No recorded changes yet — history accumulates with each release.
Data sourced from Australian Government publications · Not an official government service